Neuronetics Stock Soars 7.25% on Institutional Investments

On August 13, 2025, Neuronetics' stock surged by 7.25% in pre-market trading, reflecting a significant uptick in investor interest and confidence in the company's prospects.

Madryn Asset Management, LP reported a beneficial ownership of 20,737,061 shares of Neuronetics, Inc. (STIM), representing 31.4% of the total shares. This disclosure included details of Rule 144 sales on August 8, 2025, at approximately $3.72 per share, indicating a strategic move by the firm to manage its holdings.

Citizens Financial Group Inc. made a notable investment in Neuronetics, acquiring 83,000 shares worth $305,000, which represents 0.13% of the company's total shares. This investment underscores the growing institutional interest in Neuronetics' potential for growth and innovation in the neurohealth sector.